A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs

Abstract Background Enteric‐coated omeprazole capsules are commonly used as a gastric acid suppressant in dogs. However, the efficacy of this formulation has not been evaluated for clinical use in dogs. Hypothesis/Objectives To evaluate the efficacy of a 10 mg PO omeprazole capsule (TriviumVet) unde...

Full description

Bibliographic Details
Main Authors: Ann Gaier, Josh Price, Louise Grubb, Stuart Fitzgerald, M. Katherine Tolbert
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.16061
_version_ 1811182139649032192
author Ann Gaier
Josh Price
Louise Grubb
Stuart Fitzgerald
M. Katherine Tolbert
author_facet Ann Gaier
Josh Price
Louise Grubb
Stuart Fitzgerald
M. Katherine Tolbert
author_sort Ann Gaier
collection DOAJ
description Abstract Background Enteric‐coated omeprazole capsules are commonly used as a gastric acid suppressant in dogs. However, the efficacy of this formulation has not been evaluated for clinical use in dogs. Hypothesis/Objectives To evaluate the efficacy of a 10 mg PO omeprazole capsule (TriviumVet) undergoing FDA approval to increase gastric pH in dogs. We hypothesized that encapsulated omeprazole would significantly increase the gastric pH compared to placebo and reach pH goals extrapolated from people for the treatment of esophagitis and duodenal ulceration. Animals Six healthy research dogs. Methods Randomized, blinded, 2‐way crossover study. Dogs were PO administered omeprazole at 0.5 to 1.0 mg/kg or placebo (empty gelatin capsules) twice‐daily for 5 days. The intragastric pH was recorded on days 2 to 5 of treatment. Mean pH and the mean percentage time (MPT) intragastric pH was ≥3 or ≥4 were compared between and within treatment groups. Results Dogs treated with omeprazole had a significantly higher MPT ± SD intragastric pH ≥3 (91.2% ± 11.0%), ≥4 (86.9% ± 13.7%) and mean ± SD pH (5.4 ± 0.8) than dogs treated with placebo (19.7% ± 15.5%, 28.3 ± 20.7, and 2.4 ± 1.0, respectively) (P < .001 for all). Conclusions and Clinical Importance The 10 mg enteric‐coated omeprazole capsule PO administered evaluated in this study is an effective gastric acid suppressant in healthy dogs.
first_indexed 2024-04-11T09:28:10Z
format Article
id doaj.art-a0e88d8036f34937a6dae69a9fd54ba9
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-04-11T09:28:10Z
publishDate 2021-03-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-a0e88d8036f34937a6dae69a9fd54ba92022-12-22T04:31:59ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762021-03-0135288789110.1111/jvim.16061A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogsAnn Gaier0Josh Price1Louise Grubb2Stuart Fitzgerald3M. Katherine Tolbert4North Carolina State University, College of Veterinary Medicine Raleigh North Carolina USADepartment of Small Animal, Clinical Sciences University of Tennessee, College of Veterinary Medicine Knoxville Tennessee USATriviumVet Waterford IrelandTriviumVet Waterford IrelandGastrointestinal Laboratory, Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences Texas A&M University College Station Texas USAAbstract Background Enteric‐coated omeprazole capsules are commonly used as a gastric acid suppressant in dogs. However, the efficacy of this formulation has not been evaluated for clinical use in dogs. Hypothesis/Objectives To evaluate the efficacy of a 10 mg PO omeprazole capsule (TriviumVet) undergoing FDA approval to increase gastric pH in dogs. We hypothesized that encapsulated omeprazole would significantly increase the gastric pH compared to placebo and reach pH goals extrapolated from people for the treatment of esophagitis and duodenal ulceration. Animals Six healthy research dogs. Methods Randomized, blinded, 2‐way crossover study. Dogs were PO administered omeprazole at 0.5 to 1.0 mg/kg or placebo (empty gelatin capsules) twice‐daily for 5 days. The intragastric pH was recorded on days 2 to 5 of treatment. Mean pH and the mean percentage time (MPT) intragastric pH was ≥3 or ≥4 were compared between and within treatment groups. Results Dogs treated with omeprazole had a significantly higher MPT ± SD intragastric pH ≥3 (91.2% ± 11.0%), ≥4 (86.9% ± 13.7%) and mean ± SD pH (5.4 ± 0.8) than dogs treated with placebo (19.7% ± 15.5%, 28.3 ± 20.7, and 2.4 ± 1.0, respectively) (P < .001 for all). Conclusions and Clinical Importance The 10 mg enteric‐coated omeprazole capsule PO administered evaluated in this study is an effective gastric acid suppressant in healthy dogs.https://doi.org/10.1111/jvim.16061bravo monitoringcaninegastric pHproton pump inhibitor
spellingShingle Ann Gaier
Josh Price
Louise Grubb
Stuart Fitzgerald
M. Katherine Tolbert
A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs
Journal of Veterinary Internal Medicine
bravo monitoring
canine
gastric pH
proton pump inhibitor
title A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs
title_full A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs
title_fullStr A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs
title_full_unstemmed A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs
title_short A prospective, randomized, masked, placebo‐controlled crossover study for the effect of 10 mg omeprazole capsules on gastric pH in healthy dogs
title_sort prospective randomized masked placebo controlled crossover study for the effect of 10 mg omeprazole capsules on gastric ph in healthy dogs
topic bravo monitoring
canine
gastric pH
proton pump inhibitor
url https://doi.org/10.1111/jvim.16061
work_keys_str_mv AT anngaier aprospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT joshprice aprospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT louisegrubb aprospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT stuartfitzgerald aprospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT mkatherinetolbert aprospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT anngaier prospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT joshprice prospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT louisegrubb prospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT stuartfitzgerald prospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs
AT mkatherinetolbert prospectiverandomizedmaskedplacebocontrolledcrossoverstudyfortheeffectof10mgomeprazolecapsulesongastricphinhealthydogs